Novartis

تفاصيل التقرير

ESG Index: Access to medicines

ESG Index: Access to medicines
Our approach and targets
Improving access to medicines remains one of the world’s greatest healthcare
challenges. At Novartis, we know that building trust with society depends not only on
finding new treatments but also on making them available to as many people as
possible. 
Through the Novartis Access Principles, we seek to expand access to our medicines to
underserved patient populations in both developed and developing countries, while
addressing major global...
نوع التقرير
تقرير استدامة شامل
اللغة
الإنجليزية
السنة
الصيغة
PDF
معايير التقرير: GRI ISSB UN SDG
تنزيل التقرير